Lilly's (LLY) Solanezumab Phase 3 Miss is Credit-Negative Event - Moody's

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. IBM
5. ACN
6. NVDA
7. PRIM
8. META
9. SPY
10. TSLA

Go back to Lilly's (LLY) Solanezumab Phase 3 Miss is Credit-Negative Event - Moody's
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1097.74 -4.34 (0.39%)
Previous Close $1102.08    52 Week High $88.16 
Open $1117.00    52 Week Low $67.88 
Day High $1122.02    P/E 254.11 
Day Low $1079.22    EPS $4.32 
Volume 902,461